NCVI Enterprises Limited, a promoter group entity of IOL Chemicals and Pharmaceuticals Limited, acquired 7,00,000 equity shares worth ₹5.14 crore through open market transactions. The acquisition increased NCVI's shareholding from 16.20% to 16.44%, representing a 0.24% increase in ownership.

NCVI Enterprises Acquires 7 Lakh IOL Chemicals Shares Worth ₹5.14 Crore

IOL Chemicals & Pharmaceuticals Limited disclosed that its promoter group entity NCVI Enterprises Limited has acquired 7,00,000 equity shares through open market transactions on 18th March 2026, as per regulatory filing under SEBI's Prohibition of Insider Trading Regulations, 2015.

Transaction Overview

The acquisition was completed through on-market purchases, with NCVI Enterprises Limited increasing its shareholding in the pharmaceutical company. The transaction details were formally disclosed to stock exchanges on 19th March 2026.

Transaction Parameter: Details Shares Acquired: 7,00,000 Transaction Value: ₹5,14,08,739 Acquisition Date: 18th March 2026 Mode: On Market Disclosure Date: 19th March 2026

Shareholding Pattern Changes

Following the acquisition, NCVI Enterprises Limited's direct shareholding in IOL Chemicals increased from 4,75,50,695 shares to 4,82,50,695 shares, representing a change from 16.20% to 16.44% of the total equity.

Shareholding Position: Before Acquisition After Acquisition NCVI Enterprises Shares: 4,75,50,695 4,82,50,695 Percentage Holding: 16.20% 16.44% Change: - +0.24%

Regulatory Compliance

The disclosure was made under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, and submitted to both National Stock Exchange and BSE Limited. The filing was signed by Abhiraj Gupta, Director of NCVI Enterprises Limited, and communicated through IOL Chemicals' Company Secretary Abhay Raj Singh.

Company Profile

IOL Chemicals and Pharmaceuticals Limited operates with equity structure comprising shares of ₹2 each, with NCVI Enterprises Limited being a key promoter group entity. The company maintains listings on both major Indian stock exchanges with trading symbols IOLCP on NSE and security code 524164 on BSE.

IOL Chemicals & Pharmaceuticals Limited has disclosed that its promoter group entity, Mayadevi Polycot Limited, has increased its shareholding in the company through an on-market acquisition. The transaction, completed on March 18, 2026, was disclosed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Latest Transaction Details

The recent shareholding acquisition involved a purchase of equity shares by Mayadevi Polycot Limited on March 18, 2026:

Parameter: Details Shares Acquired: 54,197 equity shares Transaction Value: ₹40,00,210 Transaction Date: March 18, 2026 Mode of Acquisition: On Market Transaction Type: Buy

Updated Shareholding Position

The acquisition has resulted in an increase in Mayadevi Polycot Limited's individual stake in IOL Chemicals and Pharmaceuticals Limited:

Shareholding Position: Before Transaction After Transaction Mayadevi Polycot Shares: 6,38,91,133 6,39,45,330 Individual Percentage: 21.76% 21.78% Change: - +0.02%

The increase of 0.02 percentage points in shareholding reflects the promoter group entity's continued investment in the company.

Regulatory Compliance and Disclosure

The disclosure was made in accordance with Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. IOL Chemicals and Pharmaceuticals Limited communicated this information to both the National Stock Exchange of India Limited (NSE) and BSE Limited on March 19, 2026.

Regulatory Details: Information NSE Symbol: IOLCP BSE Security Code: 524164 Company ISIN: INE485C01029 Disclosure Date: March 19, 2026 Signatory: Varinder Gupta, Director (DIN: 00044068)

Company Structure

Mayadevi Polycot Limited is classified as a promoter group entity of IOL Chemicals and Pharmaceuticals Limited. The entity is based at 86 Industrial Area A, Ludhiana. The disclosure was signed by Varinder Gupta, Director of Mayadevi Polycot Limited, and countersigned by Abhay Raj Singh, Sr. Vice President & Company Secretary of IOL Chemicals and Pharmaceuticals Limited.

The transaction represents a strategic investment by the promoter group entity, demonstrating continued confidence in the company's prospects and reinforcing their commitment to the company's growth trajectory.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.